The following is a summary of “Mendelian randomization reveals causal effect of Hashimoto's thyroiditis on immune ...

Immune thrombocytopenia (ITP) is the second biggest cause of low platelets in pregnant women. It's not brought on by pregnancy, however. Rather, it's a malfunction of the immune system.

One of the most common causes of thrombocytopenia, immune thrombocytopenic purpura (ITP), can cause a severe reduction in the circulating platelet count, with a subset of affected individuals not ...

More information: Zhangbiao Long et al, Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac, Frontiers of Medicine (2024). DOI: 10.1007 ...

Purpose. A case of a patient who developed thrombotic thrombocytopenic purpura (TTP) after consuming a weight-loss product containing green tea is reported. Summary. A 38-year-old, 68-kg Caucasian ...

PTP is characterized by the development of severe, sudden and self-limiting thrombocytopenia occurring 5-10 days after a blood transfusion. The recipients always have a history of sensitization ...

in rare bleeding disorder primary immune thrombocytopenia (ITP), but failed to show a benefit with the drug compared to placebo. Specifically, Vyvgart Hytrulo was not statistically superior to ...

2022 Apr 14;386(15):1421-1431 Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) network. Moulis G, Cooper N, Ghanima W, González-López T, Kühne T, ...

EDEN — Emergency Department Nurse, Maggie Reeder, RN, was honored with The DAISY Award for Extraordinary Nurses at UNC Health Rockingham. Nursing leadership along with senior administrators gathered o ...

The European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP), which is also ...

The therapy is also being reviewed in the European Union (EU), China and the US for immune thrombocytopenia (ITP). The FDA has set a target action date of 29 August 2025 for its decision on ITP ...